|
Volumn 410, Issue 1, 2000, Pages 53-59
|
Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine
a
Research Center
*
(Spain)
|
Author keywords
5 HT1B 1D receptor agonist; Almotriptan; Cardiovascular safety; Migraine
|
Indexed keywords
ALMOTRIPTAN;
SUMATRIPTAN;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CARDIOVASCULAR EFFECT;
CORONARY ARTERY BLOOD FLOW;
DRUG SAFETY;
HEART RATE;
MALE;
MEAN ARTERIAL PRESSURE;
MIGRAINE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
BLOOD PRESSURE;
CARDIOVASCULAR SYSTEM;
CATS;
CORONARY CIRCULATION;
CORONARY VESSELS;
DOGS;
ELECTROCARDIOGRAPHY;
FEMALE;
GUINEA PIGS;
HEART RATE;
INDOLES;
INJECTIONS, SUBCUTANEOUS;
MACACA FASCICULARIS;
MALE;
MIGRAINE DISORDERS;
RATS;
RATS, WISTAR;
RECEPTOR, SEROTONIN, 5-HT1B;
RECEPTOR, SEROTONIN, 5-HT1D;
RECEPTORS, SEROTONIN;
SAFETY;
SEROTONIN AGONISTS;
SUMATRIPTAN;
TRYPTAMINES;
|
EID: 0034694789
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(00)00878-5 Document Type: Article |
Times cited : (17)
|
References (24)
|